Summary of clinical guidelines and recommendations with the reference to smoking
| Disease | Number of included guidelines | Number mentioning smoking, n (%) | Type of reference to smoking, n (%) | Number not mentioning smoking, n (%) | ||
|---|---|---|---|---|---|---|
| Smoking as a risk factor | Smoking cessation advice | Specific treatment/reference to guideline | ||||
| Cancer | ||||||
| Pharynx/oral cavity cancer and larynx cancer | 10 (8 UK, 2 EU) | 6 (60) (5 UK, 1 EU) | 6 (60) (5 UK, 1 EU) | 3 (30) (2 UK, 1 EU) | 2 (20) (2 UK) | 4 (40) (3 UK, 1 EU) |
| Lung cancer | 17 (4 UK, 13 EU) | 8 (47) (2 UK, 6 EU) | 6 (35) (2 UK, 4 EU) | 6 (35) (2 UK, 4 EU) | 4 (24) (2 UK, 2 EU) | 9 (53) (3 UK, 6 EU) |
| Cardiovascular | ||||||
| Abdominal aortic aneurysm | 11 (4 UK, 6 EU, 1 Intl) | 7 (64) (3 UK, 4 EU) | 7 (64) (3 UK, 4 EU) | 5 (45) (1 UK, 4 EU) | 2 (18) (2 EU) | 4 (36) (1 UK, 2 EU, 1 Intl) |
| Ischaemic heart disease and peripheral artery disease | 28 (10 UK, 18 EU) | 20 (71) (8 UK, 12 EU) | 17 (61) (7 UK, 10 EU) | 15 (54) (5 UK, 10 EU) | 7 (25) (3 UK, 4 EU) | 8 (29) (2 UK, 6 EU) |
| Mental health | ||||||
| Psychosis and schizophrenia | 18 (11 UK, 5 EU, 2 Intl) | 9 (50) (7 UK, 2 EU) | 6 (33) (4 UK, 2 EU) | 9 (50) (7 UK, 2 EU) | 8 (44) (6 UK, 2 EU) | 9 (50) (4 UK, 3 EU, 2 Intl) |
| Respiratory | ||||||
| COPD | 16 (5 UK, 11 EU) | 13 (81) (5 UK, 8 EU) | 13 (81) (5 UK, 8 EU) | 6 (36) (2 UK, 4 EU) | 5 (31) (2 UK, 3 EU) | 3 (19) (3 EU) |
| Pneumonia | 7 (5 UK, 2 EU) | 1 (14) (1 UK) | 1 (14) (1 UK) | 1 (14) (1 UK) | 1 (14) (1 UK) | 6 (86) (4 UK, 2 EU) |
| Lab confirmed influenza | 4 (4 UK) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (100) (4 UK) |
| Sleep apnoea | 5 (1 UK, 1 EU, 3 Intl) | 1 (20) (1 Intl) | 1 (20) (1 Intl) | 0 (0) | 0 (0) | 4 (80) (1 UK, 1 EU, 2 Intl) |
| Others | ||||||
| Bulimia | 5 (5 UK) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 5 (100) (5 UK) |
| Hearing loss | 8 (3 UK, 2 EU, 3 Intl) | 1 (12) (1 Intl) | 1 (12) (1 Intl) | 0 (0) | 0 (0) | 7 (88) (3 UK, 1 EU, 3 Intl) |
| Hernia | 13 (5 UK, 5 EU, 3 Intl) | 7 (54) (3 UK, 2 EU, 2 Intl) | 7 (54) (3 UK, 2 EU, 2 Intl) | 1 (8) (1 UK) | 2 (15) (2 Intl) | 6 (46) (2 UK, 3 EU, 1 Intl) |
| Rheumatoid arthritis | 17 (10 UK, 7 EU) | 5 (29) (3 UK, 2 EU) | 4 (24) (3 UK, 1 EU) | 4 (24) (2 UK, 2 EU) | 0 (0) | 12 (71) (7 UK, 5 EU) |
| Total | 159 (75 UK, 72 EU, 12 Intl) | 78 (49%) (37 UK, 38 EU, 3 Intl) | 69 (43%) (33 UK, 33 EU, 3 Intl) | 50 (31%) (23 UK, 27 EU) | 30 (19%) (17 UK, 13 EU) | 81 (51%) (38 UK, 34 EU, 9 Intl) |
COPD = chronic obstructive pulmonary disease; EU = European; Intl = international.